Skip to main content
Gentian Diagnostics ASA logo

Gentian Diagnostics ASA — Investor Relations & Filings

Ticker · GENT ISIN · NO0010748866 LEI · 5967007LIEEXZXHNM861 OL Manufacturing
Open in API
Filings indexed 468 across all filing types
Latest filing 2018-05-24 AGM Information
Country NO Norway
Listing OL GENT

About Gentian Diagnostics ASA

https://www.gentian.com/

Gentian Diagnostics ASA is a medical diagnostics company that develops, manufactures, and markets innovative in vitro diagnostic (IVD) reagents. The company specializes in turbidimetric immunoassays designed for open clinical chemistry platforms, aiming to enhance laboratory efficiency and support better clinical treatment decisions. Its portfolio and pipeline of diagnostic tests address biomarkers in high-impact medical areas, including kidney disease, cardiac disease, inflammation, and infection. Key products include assays for Cystatin C, NGAL, and Calprotectin. In addition to its human diagnostics portfolio, the company provides diagnostic solutions for the veterinary market. Gentian serves a global customer base through original equipment manufacturer (OEM) partners, distributors, and healthcare providers.

Recent filings

Filing Released Lang Actions
Notice of annual general meeting
AGM Information Classification · 99% confidence The document explicitly states 'Notice of annual general meeting' and provides the date, time, and location for the event. This directly corresponds to materials related to the Annual General Meeting (AGM). Therefore, the appropriate classification is AGM Information (AGM-R). The document is very short, but since it is the notice itself rather than an announcement *about* the notice, AGM-R is more specific than RPA or RNS.
2018-05-24 English
2017 Annual Report
Annual Report Classification · 100% confidence The document is titled 'Annual Report 2017' and contains comprehensive financial statements (Statement of Comprehensive Income, Statement of Financial Position, Statement of Changes in Equity, Cash Flow Statement) and detailed notes for the fiscal year 2017. It covers company activity, management's discussion, and audited financial data, fitting the definition of a 10-K (Annual Report). FY 2017
2018-05-15 English
2017 Annual Report
Report Publication Announcement Classification · 100% confidence The document explicitly states it is the '2017 Annual Report' and mentions that the 'Annual Report for 2017 is attached'. However, the document text is extremely short (613 characters) and functions primarily as an announcement that the full report is available, rather than containing the comprehensive financial data expected of a full 10-K or IR filing. According to Rule #2 (The 'MENU VS MEAL' Rule), a short announcement stating a report is attached or published should be classified as a Report Publication Announcement (RPA). Although the content is about the Annual Report, the format is that of a publication notice.
2018-05-15 English
First Quarter Financial Report
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive financial report for the first quarter of 2018 (1Q18) for Gentian Diagnostics AS. It includes detailed financial statements (Statement of Comprehensive Income, Statement of Financial Position, and Cash Flow Statement), management commentary on financial performance, operational status, and shareholder information. Since it covers a period shorter than a full fiscal year and contains substantive financial data, it is classified as an Interim/Quarterly Report. Q1 2018
2018-05-15 English
First Quarter Financial Report
Earnings Release Classification · 100% confidence The document is titled 'First Quarter Financial Report' and explicitly announces the results for the first quarter of 2018, listing key financial highlights (revenue, sales growth). This strongly suggests an Earnings Release (ER) or an Interim/Quarterly Report (IR). However, the document is very short (869 characters) and concludes with the statement: 'Please find the report enclosed. The report will also be made available on www.gentian.no.' According to Rule #2 (The 'MENU VS MEAL' Rule), a short announcement stating that the full report is enclosed or published points to a Report Publication Announcement (RPA) rather than the comprehensive report itself (IR or ER). Since this is an announcement about the publication of a quarterly report, RPA is the most appropriate classification. Q1 2018
2018-05-15 English
Share option program and compensation policy
Remuneration Information Classification · 95% confidence The document details the establishment of a share option program for key personnel, including the number of options, vesting schedules, strike prices, and the Board of Directors' statement on remuneration guidelines. This content directly relates to executive compensation, specifically share-based incentives, which falls under the scope of remuneration reports or proxy statements detailing compensation plans. The definition for Remuneration Information (DEF 14A) covers reports detailing compensation for top executives and directors. Although this is not a formal SEC DEF 14A filing, in the context of general corporate filings, a detailed statement on remuneration guidelines and share-based incentive plans aligns best with the 'Remuneration Information' category, as opposed to a general capital change (SHA) or a general regulatory filing (RNS).
2018-05-14 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.